• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用无标记电可切换纳米杠杆技术验证组蛋白去乙酰化酶重排配体(SirReals)的慢脱动力学。

Validation of the Slow Off-Kinetics of Sirtuin-Rearranging Ligands (SirReals) by Means of Label-Free Electrically Switchable Nanolever Technology.

机构信息

Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich Alexander University Erlangen-Nürnberg, Nikolaus-Fiebiger-Strasse 10, 91058, Erlangen, Germany.

Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, Albertstrasse 25, 79104, Freiburg im Breisgau, Germany.

出版信息

Chembiochem. 2020 Apr 17;21(8):1161-1166. doi: 10.1002/cbic.201900527. Epub 2020 Jan 22.

DOI:10.1002/cbic.201900527
PMID:31692222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7217041/
Abstract

We have discovered the sirtuin-rearranging ligands (SirReals) to be highly potent and selective inhibitors of the NAD -dependent lysine deacetylase Sirt2. Using a biotinylated SirReal in combination with biolayer interferometry, we previously observed a slow dissociation rate of the inhibitor-enzyme complex; this had been postulated to be the key to the high affinity and selectivity of SirReals. However, to attach biotin to the SirReal core, we introduced a triazole as a linking moiety; this was shown by X-ray co-crystallography to interact with Arg97 of the cofactor binding loop. Herein, we aim to elucidate whether the observed long residence time of the SirReals is induced mainly by triazole incorporation or is an inherent characteristic of the SirReal inhibitor core. We used the novel label-free switchSENSE® technology, which is based on electrically switchable DNA nanolevers, to prove that the long residence time of the SirReals is indeed caused by the core scaffold.

摘要

我们发现,组蛋白去乙酰化酶 Sirt2 的烟酰胺腺嘌呤二核苷酸(NAD)依赖性赖氨酸去乙酰化酶的 sirtuin 重排配体(SirReals)是高度有效和选择性的抑制剂。使用带有生物素的 SirReal 和生物层干涉测量法,我们之前观察到抑制剂-酶复合物的缓慢解离速率;这被认为是 SirReals 高亲和力和选择性的关键。然而,为了将生物素连接到 SirReal 核心上,我们引入了三唑作为连接部分;X 射线共晶结构显示该连接部分与辅因子结合环的 Arg97 相互作用。在此,我们旨在阐明观察到的 SirReals 的长停留时间主要是由三唑的掺入引起的,还是 SirReal 抑制剂核心的固有特征。我们使用了基于电可切换 DNA 纳米杆的新型无标记 switchSENSE®技术,证明了 SirReals 的长停留时间确实是由核心支架引起的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2521/7217041/901841b0c4ee/CBIC-21-1161-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2521/7217041/327b7373994c/CBIC-21-1161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2521/7217041/901841b0c4ee/CBIC-21-1161-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2521/7217041/327b7373994c/CBIC-21-1161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2521/7217041/901841b0c4ee/CBIC-21-1161-g002.jpg

相似文献

1
Validation of the Slow Off-Kinetics of Sirtuin-Rearranging Ligands (SirReals) by Means of Label-Free Electrically Switchable Nanolever Technology.利用无标记电可切换纳米杠杆技术验证组蛋白去乙酰化酶重排配体(SirReals)的慢脱动力学。
Chembiochem. 2020 Apr 17;21(8):1161-1166. doi: 10.1002/cbic.201900527. Epub 2020 Jan 22.
2
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.作为强效和选择性Sirt2抑制剂的氨基噻唑:构效关系研究
J Med Chem. 2016 Feb 25;59(4):1599-612. doi: 10.1021/acs.jmedchem.5b01517. Epub 2016 Jan 7.
3
Structure-Based Development of an Affinity Probe for Sirtuin 2.基于结构的 Sirtuin 2 亲和探针的开发。
Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2252-6. doi: 10.1002/anie.201509843. Epub 2016 Jan 8.
4
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals).基于 Sirtuin 重排配体(SirReals)的蛋白水解靶向嵌合体(PROTAC)诱导 Sirtuin 2(Sirt2)化学降解。
J Med Chem. 2018 Jan 25;61(2):482-491. doi: 10.1021/acs.jmedchem.6b01872. Epub 2017 Apr 17.
5
HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)*.用于开发赖氨酸去乙酰化酶 Sirtuin 2(Sirt2)的蛋白水解靶向嵌合体(PROTAC)的 HaloTag 靶向 Sirtuin 重排配体(SirReal)*。
Chembiochem. 2020 Dec 1;21(23):3371-3376. doi: 10.1002/cbic.202000351. Epub 2020 Aug 27.
6
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.通过配体诱导活性位点重排实现对Sirt2的选择性抑制。
Nat Commun. 2015 Feb 12;6:6263. doi: 10.1038/ncomms7263.
7
Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2 - New Opportunities, New Questions.打开人类赖氨酸去乙酰化酶 Sirtuin2 的选择性口袋——新机遇,新问题。
Chem Rec. 2018 Dec;18(12):1701-1707. doi: 10.1002/tcr.201800044. Epub 2018 Jun 21.
8
Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD-Binding Site.鉴定含二酮哌嗪的 2-苯胺甲酰胺作为靶向“选择性口袋”、底物结合位点和 NAD 结合位点的强效 Sirtuin 2(SIRT2)选择性抑制剂。
J Med Chem. 2019 Jun 27;62(12):5844-5862. doi: 10.1021/acs.jmedchem.9b00255. Epub 2019 Jun 12.
9
Drug repurposing for ligand-induced rearrangement of Sirt2 active site-based inhibitors via molecular modeling and quantum mechanics calculations.药物重定位:通过分子建模和量子力学计算,研究 Sirt2 活性位点基抑制剂的配体诱导重排。
Sci Rep. 2021 May 13;11(1):10169. doi: 10.1038/s41598-021-89627-0.
10
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.基于噻吩并嘧啶酮的Sirtuin-2(SIRT2)选择性抑制剂结合于配体诱导的选择性口袋中。
J Med Chem. 2017 Mar 9;60(5):1928-1945. doi: 10.1021/acs.jmedchem.6b01690. Epub 2017 Feb 15.

引用本文的文献

1
Activation and inhibition of sirtuins: From bench to bedside.沉默调节蛋白的激活与抑制:从实验室到临床应用
Med Res Rev. 2025 Mar;45(2):484-560. doi: 10.1002/med.22076. Epub 2024 Aug 31.
2
HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)*.用于开发赖氨酸去乙酰化酶 Sirtuin 2(Sirt2)的蛋白水解靶向嵌合体(PROTAC)的 HaloTag 靶向 Sirtuin 重排配体(SirReal)*。
Chembiochem. 2020 Dec 1;21(23):3371-3376. doi: 10.1002/cbic.202000351. Epub 2020 Aug 27.

本文引用的文献

1
Celastrol Promotes Weight Loss in Diet-Induced Obesity by Inhibiting the Protein Tyrosine Phosphatases PTP1B and TCPTP in the Hypothalamus.藜芦醇通过抑制下丘脑的蛋白酪氨酸磷酸酶 PTP1B 和 TCPTP 促进饮食诱导肥胖的体重减轻。
J Med Chem. 2018 Dec 27;61(24):11144-11157. doi: 10.1021/acs.jmedchem.8b01224. Epub 2018 Dec 7.
2
Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2 - New Opportunities, New Questions.打开人类赖氨酸去乙酰化酶 Sirtuin2 的选择性口袋——新机遇,新问题。
Chem Rec. 2018 Dec;18(12):1701-1707. doi: 10.1002/tcr.201800044. Epub 2018 Jun 21.
3
Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
TPPP/p25、SIRT2 相互作用调控微管乙酰化及新型具有抗 SIRT2 活性的抗癌药物。
Sci Rep. 2017 Dec 6;7(1):17070. doi: 10.1038/s41598-017-17381-3.
4
Potent mechanism-based sirtuin-2-selective inhibition by an -generated occupant of the substrate-binding site, "selectivity pocket" and NAD-binding site.基于机制的强效沉默调节蛋白2选择性抑制作用,由底物结合位点、“选择性口袋”和烟酰胺腺嘌呤二核苷酸结合位点的生成占据者介导。
Chem Sci. 2017 Sep 1;8(9):6400-6408. doi: 10.1039/c7sc02738a. Epub 2017 Jul 21.
5
Drug target residence time: a misleading concept.药物靶点停留时间:一个误导性概念。
Drug Discov Today. 2018 Jan;23(1):12-16. doi: 10.1016/j.drudis.2017.07.016. Epub 2017 Aug 3.
6
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.基于噻吩并嘧啶酮的Sirtuin-2(SIRT2)选择性抑制剂结合于配体诱导的选择性口袋中。
J Med Chem. 2017 Mar 9;60(5):1928-1945. doi: 10.1021/acs.jmedchem.6b01690. Epub 2017 Feb 15.
7
The Current State of NAD -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets.NAD+-依赖性组蛋白去乙酰化酶(Sirtuins)作为新型治疗靶点的现状。
Med Res Rev. 2018 Jan;38(1):147-200. doi: 10.1002/med.21436. Epub 2017 Jan 17.
8
Identification of a Selective SIRT2 Inhibitor and Its Anti-breast Cancer Activity.一种选择性SIRT2抑制剂的鉴定及其抗乳腺癌活性
Biol Pharm Bull. 2016;39(10):1739-1742. doi: 10.1248/bpb.b16-00520.
9
Structure-Based Development of an Affinity Probe for Sirtuin 2.基于结构的 Sirtuin 2 亲和探针的开发。
Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2252-6. doi: 10.1002/anie.201509843. Epub 2016 Jan 8.
10
Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.作为强效和选择性Sirt2抑制剂的氨基噻唑:构效关系研究
J Med Chem. 2016 Feb 25;59(4):1599-612. doi: 10.1021/acs.jmedchem.5b01517. Epub 2016 Jan 7.